首页> 美国卫生研究院文献>BMJ Open >The CLOSED trial; CLOnidine compared with midazolam for SEDation of paediatric patients in the intensive care unit: study protocol for a multicentre randomised controlled trial
【2h】

The CLOSED trial; CLOnidine compared with midazolam for SEDation of paediatric patients in the intensive care unit: study protocol for a multicentre randomised controlled trial

机译:CLOSED试用;重症监护病房中小儿患者镇静用CLOnidine与咪达唑仑的比较:一项多中心随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionSedation is an essential part of paediatric critical care. Midazolam, often in combination with opioids, is the current gold standard drug. However, as it is a far-from-ideal agent, clonidine is increasingly being used in children. This drug is prescribed off-label for this indication, as many drugs in paediatrics are. Therefore, the CLOSED trial aims to provide data on the pharmacokinetics, safety and efficacy of clonidine for the sedation of mechanically ventilated patients in order to obtain a paediatric-use marketing authorisation.
机译:简介镇静是小儿重症监护的重要组成部分。咪达唑仑通常与阿片类药物联合使用,是目前的黄金标准药物。但是,由于可乐定是一种远离理想的药物,因此越来越多地用于儿童中。如同儿科中的许多药物一样,该药物被处方为非处方药。因此,CLOSED试验旨在提供有关可乐定对机械通气患者镇静作用的药代动力学,安全性和有效性的数据,以便获得儿科用药的销售许可。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号